These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 29196251)
21. Clinical course of asymptomatic adult moyamoya disease. Jo KI; Yeon JY; Hong SC; Kim JS Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045 [TBL] [Abstract][Full Text] [Related]
22. Strategies for and Outcome of Repeat Revascularization Surgery for Moyamoya Disease: An American Institutional Series. Teo M; Johnson J; Steinberg GK Neurosurgery; 2017 Nov; 81(5):852-859. PubMed ID: 28605467 [TBL] [Abstract][Full Text] [Related]
23. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults. Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of Surgical Treatment on the Recurrent Stroke Prevention for Adult Patients With Hemorrhagic Moyamoya Disease. Wang G; Zhang X; Feng M; Liu X; Guo F J Craniofac Surg; 2017 Nov; 28(8):2113-2116. PubMed ID: 29088693 [TBL] [Abstract][Full Text] [Related]
25. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China. Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868 [TBL] [Abstract][Full Text] [Related]
26. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688 [TBL] [Abstract][Full Text] [Related]
27. Clinical features and outcome in North American adults with moyamoya phenomenon. Hallemeier CL; Rich KM; Grubb RL; Chicoine MR; Moran CJ; Cross DT; Zipfel GJ; Dacey RG; Derdeyn CP Stroke; 2006 Jun; 37(6):1490-6. PubMed ID: 16645133 [TBL] [Abstract][Full Text] [Related]
28. Early Surgery for Moyamoya Is Not Associated with Worse Outcomes: Analysis of a North American Adult Cohort. Reed LK; Soto JM; Benardete EA World Neurosurg; 2023 Jun; 174():e53-e61. PubMed ID: 36871651 [TBL] [Abstract][Full Text] [Related]
29. Outcomes after surgical revascularization for adult Moyamoya disease: A Southeast Asian tertiary centre experience. Teo CKA; Zheng Y; Lin JB; Teoh HL; Chan BPL; Sharma VK; Teo K; Nga VDW; Yeo TT J Clin Neurosci; 2024 Jan; 119():116-121. PubMed ID: 38006812 [TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series. Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of Bypass Surgery in Adult Moyamoya Disease by Onset Type. Lim YC; Lee E; Song J JAMA Netw Open; 2024 Jun; 7(6):e2415102. PubMed ID: 38842810 [TBL] [Abstract][Full Text] [Related]
32. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. Kawaguchi S; Okuno S; Sakaki T J Neurosurg; 2000 Sep; 93(3):397-401. PubMed ID: 10969936 [TBL] [Abstract][Full Text] [Related]
33. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review. Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928 [TBL] [Abstract][Full Text] [Related]
34. Outcomes in Patients with Moyamoya Syndrome and Sickle Cell Disease: A Systematic Review. Newman S; Boulter JH; Malcolm JG; Pradilla I; Pradilla G World Neurosurg; 2020 Mar; 135():165-170. PubMed ID: 31790841 [TBL] [Abstract][Full Text] [Related]
35. Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease. Lai PMR; Patel NJ; Frerichs KU; Patel AB; Aziz-Sultan MA; Ogilvy CS; Du R Neurosurgery; 2021 Jul; 89(2):315-322. PubMed ID: 33957674 [TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcomes After Combined Revascularization Surgery in Adult Hemorrhagic Moyamoya Disease. Jiang H; Yang H; Ni W; Lei Y; Su J; Gu Y; Xu B; Mao Y World Neurosurg; 2018 Aug; 116():e1032-e1041. PubMed ID: 29859362 [TBL] [Abstract][Full Text] [Related]
37. Direct Bypass Versus Indirect Bypass in Adult Moyamoya Angiopathy with Symptoms or Hemodynamic Instability: A Meta-analysis of Comparative Studies. Kim H; Jang DK; Han YM; Sung JH; Park IS; Lee KS; Yang JH; Huh PW; Park YS; Kim DS; Han KD World Neurosurg; 2016 Oct; 94():273-284. PubMed ID: 27423200 [TBL] [Abstract][Full Text] [Related]
38. Surgical outcomes for moyamoya angiopathy at barrow neurological institute with comparison of adult indirect encephaloduroarteriosynangiosis bypass, adult direct superficial temporal artery-to-middle cerebral artery bypass, and pediatric bypass: 154 revascularization surgeries in 140 affected hemispheres. Abla AA; Gandhoke G; Clark JC; Oppenlander ME; Velat GJ; Zabramski JM; Albuquerque FC; Nakaji P; Spetzler RF; Wanebo JE Neurosurgery; 2013 Sep; 73(3):430-9. PubMed ID: 23756739 [TBL] [Abstract][Full Text] [Related]
39. Moyamoya disease: a comparison of long term outcome of conservative and surgical treatment in India. Sundaram S; Sylaja PN; Menon G; Sudhir J; Jayadevan ER; Sukumaran S; Sreedharan SE; Sarma S J Neurol Sci; 2014 Jan; 336(1-2):99-102. PubMed ID: 24183032 [TBL] [Abstract][Full Text] [Related]
40. Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series. Zeng H; Guo Y; Li Y; Yu X; Yan F; Tan X; Xu H; Peng Y; Zhuang J; Zhou H; Fu X; Wang L; Chen G World Neurosurg; 2021 Feb; 146():e955-e960. PubMed ID: 33217589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]